BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17510401)

  • 21. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
    Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
    J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6.
    Nonomura Y; Nagasaka K; Hagiyama H; Sekine C; Nanki T; Tamamori-Adachi M; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2006 Jul; 54(7):2074-83. PubMed ID: 16802342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDK6 Degradation Is Counteracted by p16
    Schmalzbauer BS; Thondanpallil T; Heller G; Schirripa A; Sperl CM; Mayer IM; Knab VM; Nebenfuehr S; Zojer M; Mueller AC; Fontaine F; Klampfl T; Sexl V; Kollmann K
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
    Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
    Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d.
    Forget A; Ayrault O; den Besten W; Kuo ML; Sherr CJ; Roussel MF
    Cell Cycle; 2008 Dec; 7(23):3737-46. PubMed ID: 19029828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
    Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA
    Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).
    Matsuzaki Y; Takaoka Y; Hitomi T; Nishino H; Sakai T
    Oncogene; 2004 Jul; 23(31):5409-14. PubMed ID: 15107819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
    Jeffrey PD; Tong L; Pavletich NP
    Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
    Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y
    Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.
    Schnepp RW; Chen YX; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X
    Cancer Res; 2006 Jun; 66(11):5707-15. PubMed ID: 16740708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines.
    Ragione FD; Russo GL; Oliva A; Mercurio C; Mastropietro S; Pietra VD; Zappia V
    J Biol Chem; 1996 Jul; 271(27):15942-9. PubMed ID: 8663131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
    Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martín-Caballero J; Barbacid M; Carnero A; Malumbres M
    Cancer Res; 2005 May; 65(9):3846-52. PubMed ID: 15867383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The negative cell cycle regulators, p27(Kip1), p18(Ink4c), and GSK-3, play critical role in maintaining quiescence of adult human pancreatic β-cells and restrict their ability to proliferate.
    Stein J; Milewski WM; Dey A
    Islets; 2013; 5(4):156-69. PubMed ID: 23896637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors.
    Thullberg M; Bartkova J; Khan S; Hansen K; Rönnstrand L; Lukas J; Strauss M; Bartek J
    FEBS Lett; 2000 Mar; 470(2):161-6. PubMed ID: 10734227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ; Li Y; Xiong Y; Guan KL
    Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
    Zindy F; Quelle DE; Roussel MF; Sherr CJ
    Oncogene; 1997 Jul; 15(2):203-11. PubMed ID: 9244355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma.
    Morishita A; Masaki T; Yoshiji H; Nakai S; Ogi T; Miyauchi Y; Yoshida S; Funaki T; Uchida N; Kita Y; Funakoshi F; Usuki H; Okada S; Izuishi K; Watanabe S; Kurokohchi K; Kuriyama S
    Hepatology; 2004 Sep; 40(3):677-86. PubMed ID: 15349907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R; Laín S; Ball KL; Lane DP
    Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).
    Zindy F; den Besten W; Chen B; Rehg JE; Latres E; Barbacid M; Pollard JW; Sherr CJ; Cohen PE; Roussel MF
    Mol Cell Biol; 2001 May; 21(9):3244-55. PubMed ID: 11287627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.